700 per cent returns: Board announced stock split of equity shares; FIIs increased stake!
700 per cent returns: Board announced stock split of equity shares; FIIs increased stake!
Shares of this company have gained more than 40 per cent in the last six months.
Shares of this company have gained more than 40 per cent in the last six months.
This global biotech company receives tentative approval from US FDA!
The company is committed to research and development, allocating 7.9 per cent of its revenue to this area in FY23.
The company has delivered returns of 41.8 per cent over the past year.
Tech stock surges as it sells stake in associate company to VLCC Health Care!
Trending retail stock gains momentum and surges 240 per cent in last five years!
EBITDA levels witnessed a hike of 50.70 per cent from corresponding quarter last year to Rs 107 crore.
Shares of this micro-cap company hit upper circuit as it announces their business expansion!
On Monday, shares of the company surged by 19.97 per cent and reached its upper circuit of Rs 27.64. Moreover, the stock had a spurt in volume by more than 12.64 times.
The company has given great returns of 81 per cent over the past 3 years and have given excellent returns of 122 per cent over the past 5 years.
Do rising covid cases present an opportunity for these stocks? Check out the best performers in the healthcare industry!
Here is a list of the best performing healthcare stocks that have wowed investors!
Here is a list of the best performing healthcare stocks that have wowed investors!
Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?
Advent is expected to buy 51 per cent of the promoter’s stake in the company and launch an open offer for an additional 26 per cent
The company released a press release on Monday, stating Advent International has entered into definitive agreement to acquire significant stake in the company and intends to explore the merger of its portfolio company
Shares below Rs 100: Only buyers were seen in these stocks on December 21!
BSE Healthcare surprised investors with gains of about 2 per cent in such a lackluster market, led by IOL Chemicals and Pharmaceuticals.
BSE Healthcare surprised investors with gains of about 2 per cent in such a lackluster market, led by IOL Chemicals and Pharmaceuticals.
Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it?
This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness.
This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness.
This pharma company stock went 8 per cent high, do you own it?
With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.
This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.
Overnight Digest: Stocks to keep an eye on August 30
Keep an eye on these stocks in tomorrow's trading session.
At the time of Monday’s closing bell, the markets tanked, owing to the heavy sell-off prompted by Fed Chairman’s comments on inflation on Friday.
This news helped Aarti Drugs to surge 11 per cent on August 17
Aarti Drugs Ltd is involved in the manufacturing and selling of Active Pharmaceutical Ingredients, Pharma Intermediates, Specialty Chemicals, and Formulations.
The shares of Aarti Drugs are rallying due to news regarding imposing anti-dumping duty on Chinese pharma companies to sell Ofloxacin and other intermediates in the Indian market.
LIC sells a stake worth Rs 3882 crore in Sun Pharmaceutical
Sun pharma has showcased poor 5-year growth numbers
Sun pharma has showcased poor 5-year growth numbers